Translate
About
Neurogene Inc (NASDAQ:NGNE) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors
Mar 24 2026
Neurogene Reports Full Year 2025 Financial Results and Highlights Recent Updates
Mar 11 2026
Neurogene to Participate in Stifel 2026 Virtual CNS Forum
Feb 26 2026
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
Feb 5 2026
Neurogene to Participate in Upcoming Investor Conferences
Financials
Revenue
$0
Market Cap
$332.82 M
EPS
-4.21